TuHURA Biosciences, Inc.
HURA
$2.42
$0.020.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 82.97% | 124.76% | 31.83% | 139.54% | 69.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.75% | 80.41% | 65.14% | 52.35% | 97.66% |
| Operating Income | -59.75% | -80.41% | -65.14% | -52.35% | -97.66% |
| Income Before Tax | -12.77% | -27.31% | -80.88% | -37.63% | -123.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.77% | -27.31% | -80.88% | -37.63% | -123.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.77% | -27.31% | -80.88% | -37.63% | -123.55% |
| EBIT | -59.75% | -80.41% | -65.14% | -52.35% | -97.66% |
| EBITDA | -59.85% | -81.25% | -66.41% | -53.19% | -99.70% |
| EPS Basic | 18.88% | 73.91% | 50.54% | 61.39% | -299.24% |
| Normalized Basic EPS | -14.16% | 70.76% | 70.80% | 61.38% | -271.84% |
| EPS Diluted | 18.88% | 73.91% | 50.54% | 61.39% | -291.29% |
| Normalized Diluted EPS | -14.16% | 70.76% | 70.80% | 61.38% | -271.84% |
| Average Basic Shares Outstanding | 39.03% | 316.03% | 265.85% | 256.55% | -43.95% |
| Average Diluted Shares Outstanding | 39.03% | 316.03% | 265.85% | 256.55% | -43.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |